Chemistry:Diphenylpyraline
From HandWiki
Short description: Chemical compound
Clinical data | |
---|---|
Other names | 4-(diphenylmethoxy)-1-methyl-piperidine |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral, Topical |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Elimination half-life | 24–40 hours[1] |
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
IUPHAR/BPS | |
DrugBank |
|
ChemSpider |
|
UNII | |
KEGG |
|
ChEBI | |
ChEMBL | |
Chemical and physical data | |
Formula | C19H23NO |
Molar mass | 281.399 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Diphenylpyraline (DPP; sold as Allergen, Arbid, Belfene, Diafen, Hispril, Histyn, Lergobine, Lyssipol, Mepiben, Neargal) is a first-generation antihistamine with anticholinergic effects of the diphenylpiperidine class.[2][3][4] It is marketed in Europe for the treatment of allergies.[2][3][5] DPP has also been found to act as a dopamine reuptake inhibitor and produces hyperactivity in rodents.[6] It has been shown to be useful in the treatment of Parkinsonism.[7]
Synthesis
References
- ↑ "Half-life of diphenylpyraline in man". Journal of Pharmacokinetics and Biopharmaceutics 2 (3): 191–5. June 1974. doi:10.1007/BF01059761. PMID 4156058.
- ↑ 2.0 2.1 Swiss Pharmaceutical Society (2000). Index Nominum 2000: International Drug Directory (Book with CD-ROM). Boca Raton: Medpharm Scientific Publishers. ISBN 3-88763-075-0. https://books.google.com/books?id=5GpcTQD_L2oC&q=Diphenylpyraline&pg=PA358.
- ↑ 3.0 3.1 "Diphenylpyraline (Lergobine) in the treatment of patients suffering from allergic and vasomotor rhinitis". J Int Med Res 5 (1): 37–41. 1977. doi:10.1177/030006057700500106. PMID 14039.
- ↑ "Antimuscarinic effects of antihistamines: quantitative evaluation by receptor-binding assay". Japanese Journal of Pharmacology 43 (3): 277–82. March 1987. doi:10.1254/jjp.43.277. PMID 2884340.
- ↑ "Antihistamine Drugs". Synthesis of Essential Drugs. Amsterdam: Elsevier. 2006. ISBN 0-444-52166-6. https://books.google.com/books?id=Jjc7KYWZdOYC&q=Diphenylpyraline&pg=PA230.
- ↑ "Diphenylpyraline, a histamine H1 receptor antagonist, has psychostimulant properties". Eur J Pharmacol 506 (3): 237–40. 2005. doi:10.1016/j.ejphar.2004.11.017. PMID 15627433.
- ↑ "Diphenylpyraline-responsive parkinsonism in cerebrotendinous xanthomatosis: long-term follow up of three patients". J Neurol Sci 182 (2): 95–7. 2001. doi:10.1016/S0022-510X(00)00441-X. PMID 11137513.
- ↑ Knox LH, Kapp R, "1-Alkylpiperidyl-4-benzhydryl ethers, acid salts thereof and their preparation", US patent 2479843, issued 23 August 1949, assigned to Nopco Chemical Company.
- ↑ Schuler WA, "Verfahren zur Herstellung von basischen Benzhydryläthern [Process for the production of basic benzhydrylethers]", DE patent 934890, issued 10 November 1955.
[[Chemistry:AntihistAntihistamine]]s (R06) | |
---|---|
Benzimidazoles (*) | |
Diarylmethanes |
|
Ethylenediamines | |
Tricyclics | |
Others |
|
For topical use |
Dopaminergics |
| ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Anticholinergics | |||||||||||
Others | |||||||||||
|
D1-like |
| ||||
---|---|---|---|---|---|
D2-like |
| ||||
DAT (DRIs) |
| ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NET (NRIs) |
| ||||||||||||||
SERT (SRIs) |
| ||||||||||||||
VMATs | |||||||||||||||
Others |
| ||||||||||||||
0.00 (0 votes)
|